Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

被引:0
作者
Yifen Lin
Xiangbin Zhong
Menghui Liu
Shaozhao Zhang
Zhenyu Xiong
Yiquan Huang
Yongqiang Fan
Xingfeng Xu
Yue Guo
Yuqi Li
Xiuting Sun
Huimin Zhou
Daya Yang
Xiaomin Ye
Xinxue Liao
Xiaodong Zhuang
机构
[1] First Affiliated Hospital of Sun Yat-Sen University,Cardiology Department
[2] NHC Key Laboratory of Assisted Circulation (Sun Yat-Sen University),undefined
来源
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词
Heart failure with preserved ejection fraction; Risk stratification; Efficacy; Spironolactone;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:323 / 331
页数:8
相关论文
共 287 条
[1]  
Ponikowski P(2016)2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 37 2129-2200
[2]  
Voors AA(2006)Trends in prevalence and outcome of heart failure with preserved ejection fraction New Engl J Med 355 251-259
[3]  
Anker SD(2017)2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America J Am Coll Cardiol 70 776-803
[4]  
Bueno H(2014)Spironolactone for heart failure with preserved ejection fraction New Engl J Med 370 1383-1392
[5]  
Cleland JGF(2020)Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone JACC Heart Fail 8 172-184
[6]  
Coats AJS(2011)Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction Am Heart J 162 966-972.e10
[7]  
Falk V(2004)Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial J Am Coll Cardiol 44 1025-1029
[8]  
Gonzalez-Juanatey JR(2003)Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2581-2587
[9]  
Harjola VP(2013)Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies Eur Heart J 34 1404-1413
[10]  
Jankowska EA(2019)The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study Int J Cardiol 284 42-49